TickerFacts.

Biomerica Inc (BMRA): Revenue

Annual figures by period end, from SEC filings.

$4.45M
Year ended 2026-05-31
-5.9%
3-year compound annual growth
-9.2%
5-year compound annual growth
$18.87M2011-05-31: $4.90M2012-05-31: $6.08M2017-05-31: $5.79M2018-05-31: $5.56M2019-05-31: $5.20M2020-05-31: $6.69M2021-05-31: $7.20M2022-05-31: $18.87M2023-05-31: $5.34M2024-05-31: $5.42M2025-05-31: $5.31M2026-05-31: $4.45M$4.45M
2011-05-31 Revenue (USD) 2026-05-31
Period endedRevenueChange YoYSource filing
2026-05-31$4.45M-16.2%2026-08-31, From 2025-06-01
2025-05-31$5.31M-1.9%2026-08-31, From 2024-06-01
2024-05-31$5.42M+1.4%2025-08-29, From 2023-06-01
2023-05-31$5.34M-71.7%2024-08-28, From 2022-06-01
2022-05-31$18.87M+162.1%2023-08-25, From 2021-06-01
2021-05-31$7.20M+7.6%2022-08-29, From 2020-06-01
2020-05-31$6.69M+28.7%2021-10-14, From 2019-06-01
2019-05-31$5.20M-6.5%2020-08-31, From 2018-06-01
2018-05-31$5.56M-3.9%2019-08-29, From 2017-06-01
2017-05-31$5.79Mn/a2018-08-29, From 2016-06-01
No annual figure between 2012-05-31 and 2017-05-31.
2012-05-31$6.08M+24.1%2012-08-29, From 2011-06-01
2011-05-31$4.90Mn/a2012-08-29, From 2010-06-01

Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Biomerica Inc (BMRA)2026-05-31$4.45M-16.2%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$4.05M+115.6%
Anbio Biotechnology (NNNN)2025-12-31$8.65M+5.6%
Aspira Women's Health Inc. (AWHL)2025-12-31$9.22M+0.4%
Volitionrx Ltd (VNRX)2025-12-31$1.73M+40.0%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$1.54M-78.0%
Immucell Corp (ICCC)2025-12-31$27.64M+4.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$40.52M+7.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$67.67M+16.9%

Compare BMRA, IMDX, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗